Home Top Movers Why Syndax Pharmaceuticals Inc. (SNDX) is Rising high Right Now. Here is...

Why Syndax Pharmaceuticals Inc. (SNDX) is Rising high Right Now. Here is what you need to know

Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors, reported its financial results for the first quarter completed on March 31, 2021. SNDX stock increased immensely adjacent to the news.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

At last check-in after-market trading, shares of Syndax Pharmaceuticals Inc. (SNDX) were up 5.99% at $17.0. SNDX’s stock closed the last session at $16.04, increasing 2.56% or $0.4. Shares of the company fluctuated between $15.11 and $16.295 throughout the day. The shares of Syndax Pharmaceuticals Inc. have advanced 6.51% in the last five days; however, they have lost -24.59% over the last month.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

First Quarter 2021 Financial Report

First-quarter 2021 R&D saw a rise of $21.9 million from $9.6 million. The substantial increment was mainly due to a rise in clinical trial activities and growing CMC activities.

General and administrative expenses for the first quarter of 2021 declined to $5.7 million versus $5.9 million. The plummet was mainly due to reduced pre-commercialization expenses for entinostat.

As of March 31, 2021, SNDX had cash, cash equivalents, and short-term investments consisting of $271.3 million and 51.6 million shares and share equivalents issued and outstanding, which is inclusive of 3.3 million pre-funded warrants

For the first quarter of 2021, SNDX depicted a net loss attributable to common stockholders of $27.7 million or $0.54 per share in comparison to $19.1 million or $0.56 per share for the same quarter of the previous year.

For the second quarter of 2021, R&D expenses are anticipated to be within the ballpark figure of $30 to $35 million, and total operating expenses are anticipated to be $35 to $40 million. For the complete year of 2021, R&D expenses are anticipated to be within a range of $90 to $100 million, and total operating expenses are anticipated to reach between $110 to $120 million.

In the beginning of the current year, SNDX had also announced that the U.S. Food and Drug Administration granted Orphan Drug Designation to axatilimabto provide treatment to patients with cGVHD and idiopathic pulmonary fibrosis.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

A strong financial report combined with positive clinical data has skyrocketed SNDX stock price. Furthermore, grants from the FDA and the potential to significantly improve the treatment paradigm for those with unmet medical needs have increased investor expectations from the company.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Related News

Edesa Biotech Inc. (EDSA) stock surged during current market trading. Here’s to know why?

Edesa Biotech Inc. (NASDAQ: EDSA) stock gained by 4.22% in the current market trading. Edesa Biotech is a clinical-stage biopharmaceutical business dedicated on the...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Cleveland BioLabs Inc. (CBLI) stock surged during after-hour session. Here’s what’s happening?

Cleveland BioLabs Inc. (NASDAQ: CBLI) stock declined by 3.58% at the last close while the CBLI stock price gains by 17.53% during the after-hour...

Why Ares Commercial Real Estate Corp (ACRE) stock plummeted on Thursday?

Ares Commercial Real Estate Corporation (ACRE) shares slipped 4.35% in after-hours on Thursday, June 17, 2021, and close the trading at $15.60. Earlier, ACRE's...

Nano-X Imaging Ltd. (NNOX) stock gained in the current market trading. Here’s to know why?

Nano-X Imaging Ltd. (NASDAQ: NNOX) stock gained by 14.90% in the current market trading. Nanox which is an Israeli company started by serial entrepreneur...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam